We serve Chemical Name:5-Iodo-4-methyl-2-pyridinamine CAS:356561-08-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Iodo-4-methyl-2-pyridinamine
CAS.NO:356561-08-5
Synonyms:5-Iodo-4-methyl-2-pyridinamine;5-iodo-4-methylpyridin-2-amine;2-PYRIDINAMINE,5-IODO-4-METHYL;MFCD06637727;2-Pyridinamine, 5-iodo-4-methyl-;5-iodo-4-methyl-2-pyridylamine;5-IODO-4-METHYL-PYRIDIN-2-YLAMINE;2-amino-5-iodo-4-picoline;2-Amino-5-iodo-4-methylpyridine
Molecular Formula:C6H7IN2
Molecular Weight:234.038
HS Code:2933399090
Physical and Chemical Properties:
Melting point:117.3-118.0°C
Boiling point:307.7±42.0 °C at 760 mmHg
Density:1.9±0.1 g/cm3
Index of Refraction:1.675
PSA:38.91000
Exact Mass:233.965378
LogP:2.52
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811 6.1 / PGIII
Packing Group:
Contact us for information like 5-Iodo-4-methyl-2-pyridinamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Amino-5-iodo-4-methylpyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-IODO-4-METHYL-PYRIDIN-2-YLAMINE Use and application,5-iodo-4-methyl-2-pyridylamine technical grade,usp/ep/jp grade.
Related News: Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high. 5-Iodo-4-methyl-2-pyridinamine manufacturer Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations. 5-Iodo-4-methyl-2-pyridinamine supplier Health officials said it remained unclear where he had developed the disease. 5-Iodo-4-methyl-2-pyridinamine vendor Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations. 5-Iodo-4-methyl-2-pyridinamine factory The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA.
